WANG Yan, YUAN Fengjuan, ZHANG Meng, et al. Acetylcholinesterase Inhibition Effect of Flavonoids from Flemigia philippinensis [J]. Science and Technology of Food Industry, 2021, 42(13): 118−124. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021040243.
Citation: WANG Yan, YUAN Fengjuan, ZHANG Meng, et al. Acetylcholinesterase Inhibition Effect of Flavonoids from Flemigia philippinensis [J]. Science and Technology of Food Industry, 2021, 42(13): 118−124. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021040243.

Acetylcholinesterase Inhibition Effect of Flavonoids from Flemigia philippinensis

More Information
  • Received Date: April 25, 2021
  • Available Online: May 20, 2021
  • In order to study the inhibitory effect of the active ingredients of the Flemigia philippinensis roots on acetylcholinesterase (AChE), the roots of the Flemigia philippinensis were used as raw materials, and different solvent systems were applied to fractionate and extract flavonoids, and then further separate and purify them. Reversible inhibition kinetics method were applied to study the inhibitory effect of different solvent extracts and four flavonoids on AChE and related constants. The results showed that the different solvent extracts and the four favonoids (Genistein, Philippin C, Philippin D and Flemiphilippinone A) from the roots of Flemigia philippinensis had a strong inhibitory effect on AChE. The inhibition type was mixed type inhibition, and the half inhibition concentration (IC50) was (57.86±0.67)~(127.28±1.22) µmol/L, the inhibition constant Ki was (54.8±0.43)~(120.58±1.35) µmol/L. The research results could provide a theoretical basis and experimental basis for the discovery of high-efficiency acetylcholinesterase inhibitor lead compounds and the development and comprehensive utilization of Flemigia philippinensis related foods.
  • [1]
    Uddin M S, Kabir M T, Niaz K, et al. Molecular insight into the therapeutic promise of flavonoids against alzheimer's disease[J]. Molecules,2020,25(6):1266−1296. doi: 10.3390/molecules25061266
    [2]
    Zhang W J, Tarutani A, Newell K L, et al. Novel tau filament fold in corticobasal degeneration[J]. Nature,2020,580:283−287. doi: 10.1038/s41586-020-2043-0
    [3]
    Benfante R, Lascio S D, Cardani S, et al. Acetylcholinesterase inhibitors targeting the cholinergic anti-inflammatory pathway: A new therapeutic perspective in aging-related disorders[J]. Aging - Clinical and Experimental Research,2019,33:823−834.
    [4]
    Stanciu G D, Luca A, Rusu R N, et al. Alzheimer's disease pharmacotherapy in relation to cholinergic system involvement[J]. Biomolecules,2019,10(1):40−61. doi: 10.3390/biom10010040
    [5]
    Sharma P, Srivastava P, Seth A, et al. Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies[J]. Progress in Neurobiology,2019,174:53−89. doi: 10.1016/j.pneurobio.2018.12.006
    [6]
    Fancellu G, Chand K, Tomás D, et al. Novel tacrine–benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer's Disease[J]. Journal of Enzyme Inhibition and Medicinal Chemistry,2020,35(1):211−226. doi: 10.1080/14756366.2019.1689237
    [7]
    Sharma K. Cholinesterase inhibitors as Alzheimer's therapeutics[J]. Molecular Medicine Reports,2019,20(2):1479−1487.
    [8]
    Saxena M, Dubey R. Target enzyme in Alzheimer's disease: Acetylcholinesterase inhibitors[J]. Current Topics in Medicinal Chemistry,2019,19(4):264−275. doi: 10.2174/1568026619666190128125912
    [9]
    Harald H, Marsel M M, Claudio A C, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease[J]. Brain A Journal of Neurology,2018,141:1917−1933. doi: 10.1093/brain/awy132
    [10]
    王晓珍, 王蓉. 阿尔茨海默病的药物治疗及研发进展[J]. 中国新药杂志,2019,28(24):2960−2964. [Wang X Z, Wang R. Drug treatment and development progress of Alzheimer's disease[J]. Chinese Journal of New Drugs,2019,28(24):2960−2964].
    [11]
    国家药典委员会. 中国人民共和国药典2010 版·Ⅰ部[M]. 北京: 化学工业出版社, 2010: 附录22, 37, 47−49, 56−57.
    [12]
    Shiao Y J, Wang C N, Wang W Y, et al. Neuroprotectiveflavonoids from Flemingia macrophylla[J]. Planta medicine,2005,71(9):835−840. doi: 10.1055/s-2005-871297
    [13]
    Li L, Deng X, Zhang L, et al. A new coumestan with immunosuppressive activities from Flemingia philippinensis[J]. Fitoterapia,2011,82(4):615−619. doi: 10.1016/j.fitote.2011.01.019
    [14]
    Lai W C, Tsui Y T, Singab A N, et al. Phyto-SERM constitutes from Flemingia macrophylla[J]. International Journal of Molecular Sciences,2013,14(8):15578−15594. doi: 10.3390/ijms140815578
    [15]
    曾春兰, 钟正贤, 卢文杰, 等. 大叶千斤拔药理作用研究[J]. 中医药导报,2011,17(7):79−81. doi: 10.3969/j.issn.1672-951X.2011.07.042
    [16]
    陈一, 李开双. 千斤拔的镇痛和抗炎作用[J]. 广西医学,1993,15(2):77−79.
    [17]
    李宝强, 宋启示. 大叶千斤拔根的化学成分[J]. 中草药,2009(2):179−182. doi: 10.3321/j.issn:0253-2670.2009.02.004
    [18]
    袁建新, 倪立新, 冯凯, 等. 千斤拔, 人参茎叶皂甙对 Wistar 大鼠坐骨神经损伤保护作用的实验研究[J]. 中国煤炭工业医学杂志,2002,5(4):405−405.
    [19]
    赵节绪, 曲绍春. 千斤拔对实验性蛛网膜下腔出血急性期脑组织及血脑屏障作用[J]. 白求恩医科大学学报,1997,23(5):489−491.
    [20]
    Pan B S, Kuo Y Y, Chen T Y, et al. Inflammatory activities of two different species of a Chinese herb I-Tiao-Gung[J]. Life Sciences,2005,77(22):2830−2839. doi: 10.1016/j.lfs.2005.05.027
    [21]
    Li H, Zhai F, Liu Z. Chemical constituents and bioactivities of the plants of Genus Flemingia Roxb. et Ait. (Leguminosae)[J]. Combinatorial Chemistry & High Throughput Screening,2012,15(8):611−622.
    [22]
    Sun G, Xing C, Zeng L, et al. Flemingia philippinensis flavonoids relieve bone erosion and inflammatory mediators in CIA mice by downregulating NF- κ B and MAPK pathways[J]. Mediators of Inflammation,2019:1−11.
    [23]
    Jeong K, Wang Y, Song Y, et al. Antioxidant activities of phenolic metabolites from Flemingia philippinensis Merr. et rolfe and their application to dna damage protection[J]. Molecules,2018,23(4):816. doi: 10.3390/molecules23040816
    [24]
    Cho H D, Lee J H, Moon K D, et al. Auriculasin-induced ROS causes prostate cancer cell death via induction of apoptosis[J]. Food and Chemical Toxicology,2018,111:660−669. doi: 10.1016/j.fct.2017.12.007
    [25]
    Wang Y, Curtis-Long M J, Yuk H J, et al. Bacterial neuraminidase inhibitory effects of prenylated isoflavones from roots of Flemingia philippinensis[J]. Bioorganic & Medicinal Chemistry,2013,21(21):6398−6404.
    [26]
    胡艳秋, 苏瑾, 田鸣. 中药抗阿尔茨海默病的研究进展[J]. 黑龙江医药科学,2016,39(6):12−15. doi: 10.3969/j.issn.1008-0104.2016.06.005
    [27]
    宋庆, 张赟彬. 豆豉中乙酰胆碱酯酶抑制剂的提取与富集工艺研究[J]. 食品工业科技,2011,32(3):285−288.
    [28]
    Xue Z, Feng W, Cao J, et al. Antioxidant activity and total phenolic contents in peel and pulp of chinese jujube (ziziphus jujuba mill) fruits[J]. Journal of Food Biochemistry,2010,33(5):613−629.
    [29]
    杨永涛. 罗布麻总黄酮的提取、分离纯化及其抗氧化性能研究[D]. 广州: 华南理工大学, 2018.
    [30]
    Cho J K, Ryu Y B, Curtis-Long M J, et al. Cholinestrase inhibitory effects of geranylated flavonoids from Paulownia tomentosa fruits[J]. Bioorganic & Medicinal Chemistry,2012,20(8):2595−2602.
    [31]
    Selepe M A, Drewes S E, Heerden F V. Total synthesis of the pyranoisoflavone kraussianone 1 and related isoflavones[J]. Journal of Natural Products,2010,73(10):1680−1685. doi: 10.1021/np100407n
    [32]
    Wang Y, Yuk H J, Kim J Y, et al. Novel chromenedione derivatives displaying inhibition of protein tyrosine phosphatase 1B (PTP1B) from Flemingia philippinensis[J]. Bioorganic & Medicinal Chemistry Letters,2016,26(2):318−321.
    [33]
    Wang Y, Kim J Y, Song Y H, et al. Highly potent bacterial neuraminidase inhibitors, chromenone derivatives from Flemingia philippinensis[J]. International Journal of Biological Macromolecules,2019,128:149−157. doi: 10.1016/j.ijbiomac.2019.01.105
    [34]
    Li H, Zhai F, Yang M, et al. A new benzofuran derivative from Flemingia philippinensis Merr. et rolfe[J]. Molecules,2012,17(7):7637−7644. doi: 10.3390/molecules17077637
    [35]
    袁勤生. 现代酶学. 第二版[M]. 上海: 华东理工大学出版社, 2007: 25−50.
  • Cited by

    Periodical cited type(7)

    1. 管堂飞,杨鑫,洪灿辉,肖培云,张成桂,何正春. 美洲大蠊提取物PAS840的乙酰胆碱酯酶活性抑制作用及抗氧化能力观察. 山东医药. 2024(11): 1-5 .
    2. 黄团心,李丽莉,王丽,刘媚媚,宁崇良. 蔓性千斤拔化学成分、药理作用及质量控制研究进展. 亚太传统医药. 2024(09): 250-255 .
    3. 朱笑颜,肖功定,陈洁,陈林,欧阳习叶,金剑,张水寒. 基于标准汤剂的千斤拔配方颗粒质量标准研究. 中国现代中药. 2024(11): 1971-1979 .
    4. 闫平,张彦,张迎,苏海美,柴希艳,张琳. 基于分子对接技术探讨体外酶抑制剂光果莸治疗代谢综合征的研究. 中国食品添加剂. 2023(04): 96-105 .
    5. 程研,张彦,张迎,闫平,党玉婷,井波鑫,张琳. 密花香薷体外对代谢综合征相关酶抑制活性研究. 中国野生植物资源. 2023(07): 50-60 .
    6. 熊豪,高萌,杨元丰,郭文慧,单家明,朱文杰,杨武亮. 野鸢尾苷的制备及其对小鼠离体小肠平滑肌调节作用研究. 中国新药杂志. 2023(15): 1578-1584 .
    7. 云浩程,于繁华,程杜,刘震,牛华周,侯万超,李赛男,刘春明,张语迟. NSGA-Ⅱ遗传算法结合响应面法优化桦褐孔菌活性成分提取工艺. 食品工业科技. 2022(17): 185-193 . 本站查看

    Other cited types(2)

Catalog

    Article Metrics

    Article views (315) PDF downloads (18) Cited by(9)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return